We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Elements of House User Fee Draft Would Slow Drug Reviews: Woodcock
Elements of House User Fee Draft Would Slow Drug Reviews: Woodcock
April 20, 2012
CDER Director Janet Woodcock is urging House lawmakers not to overload their omnibus user fee draft with unfunded mandates that would add unneeded “work strain” to the resource-strapped FDA, including a requirement that would expedite manufacturing changes to speed shortage drugs to market.